NASDAQ: DRMA
Dermata Therapeutics Inc Stock Ownership - Who owns Dermata Therapeutics?

Insider buying vs selling

Have Dermata Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Kathleen D. ScottDirector2026-06-1611$1.19
$13.09Sell
Munera Maria E. BedoyatoroSVP Regulatory Affairs2026-02-171,000$1.27
$1.27kBuy

1 of 1

DRMA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when DRMA insiders and whales buy or sell their stock.

DRMA Shareholders

What type of owners hold Dermata Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Proehl Investment Ventures LLC58.93%2,905,544$2.08MInsider
Gerald T. Proehl21.61%1,065,238$761.65kInsider
David F. Hale7.06%348,298$249.03kInsider
Hoose Kyri K. Van4.72%232,463$166.21kInsider
Mary Fisher3.99%196,946$140.82kInsider
Munera Maria E. Bedoyatoro1.73%85,189$60.91kInsider
Wendell Wierenga1.27%62,398$44.61kInsider
Christopher J. Nardo0.56%27,560$19.71kInsider
Andrew Seth Sandler0.49%24,184$17.29kInsider
Brittany Bradrick0.48%23,443$16.76kInsider

1 of 3

DRMA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DRMA0.00%100.00%Net Buying
CANF0.00%0.00%
PPBT0.00%1.89%
SILO0.01%13.97%Net Buying
ERNA0.00%100.00%Net Buying

Dermata Therapeutics Stock Ownership FAQ

Who owns Dermata Therapeutics?

Dermata Therapeutics (NASDAQ: DRMA) is owned by 0.00% institutional shareholders, 101.12% Dermata Therapeutics insiders, and 0.00% retail investors. Proehl Investment Ventures LLC is the largest individual Dermata Therapeutics shareholder, owning 2.91M shares representing 58.93% of the company. Proehl Investment Ventures LLC's Dermata Therapeutics shares are currently valued at $1.92M.

If you're new to stock investing, here's how to buy Dermata Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.